PHARMACEUTICAL MANUFACTURING
The right medicine to lift intra-Africa trade
Adcock said a R470m state incentive had enabled it to expand its Germiston manufacturing facility’s capacity
10 May 2017 - 05:27
Improving the quality of the local pharmaceutical manufacturing sector would boost intracontinental trade and reduce the burden the pharmaceutical industry can place on the national balance of payments deficit, Adcock Ingram CEO Andy Hall said this week. Local pharmaceutical companies imported more than a third of their active ingredients, negatively affecting the balance of payments. Adcock said a R470m state incentive had enabled it to expand its Germiston and Clayville manufacturing facilities’ capacity to produce 2-billion capsules and tablets a year.
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.